Janus Henderson Group PLC Sells 2,600 Shares of T. Rowe Price Group, Inc. (NASDAQ:TROW)

Janus Henderson Group PLC reduced its stake in shares of T. Rowe Price Group, Inc. (NASDAQ:TROW - Free Report) by 8.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,389 shares of the asset manager's stock after selling 2,600 shares during the quarter. Janus Henderson Group PLC's holdings in T. Rowe Price Group were worth $3,098,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of TROW. Barclays PLC raised its stake in T. Rowe Price Group by 13.6% during the 3rd quarter. Barclays PLC now owns 822,869 shares of the asset manager's stock valued at $89,635,000 after purchasing an additional 98,448 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in T. Rowe Price Group by 1,803.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 70,533 shares of the asset manager's stock valued at $7,977,000 after buying an additional 66,828 shares during the period. Park Avenue Securities LLC bought a new stake in T. Rowe Price Group in the 4th quarter valued at $474,000. Merit Financial Group LLC bought a new stake in T. Rowe Price Group in the 4th quarter valued at $1,502,000. Finally, Brooklyn Investment Group increased its holdings in T. Rowe Price Group by 24.6% in the 4th quarter. Brooklyn Investment Group now owns 497 shares of the asset manager's stock valued at $56,000 after buying an additional 98 shares during the period. 73.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on TROW shares. JPMorgan Chase & Co. lowered their price target on shares of T. Rowe Price Group from $110.00 to $90.00 and set an "underweight" rating on the stock in a report on Wednesday, April 16th. Morgan Stanley boosted their price target on shares of T. Rowe Price Group from $94.00 to $95.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Keefe, Bruyette & Woods reissued a "market perform" rating and issued a $113.00 price target (up previously from $111.00) on shares of T. Rowe Price Group in a report on Thursday, February 6th. The Goldman Sachs Group lowered their target price on shares of T. Rowe Price Group from $89.00 to $80.00 and set a "sell" rating on the stock in a report on Monday, April 14th. Finally, Wells Fargo & Company reduced their price target on shares of T. Rowe Price Group from $116.00 to $98.00 and set an "equal weight" rating on the stock in a research report on Tuesday, April 8th. Four research analysts have rated the stock with a sell rating and nine have issued a hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $94.09.

Insider Transactions at T. Rowe Price Group

In other news, Director Robert F. Maclellan sold 3,955 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $91.56, for a total transaction of $362,119.80. Following the completion of the transaction, the director now directly owns 42,979 shares of the company's stock, valued at $3,935,157.24. This trade represents a 8.43% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica M. Hiebler sold 968 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $96.98, for a total transaction of $93,876.64. Following the transaction, the insider now directly owns 13,611 shares of the company's stock, valued at $1,319,994.78. This represents a 6.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.00% of the company's stock.

T. Rowe Price Group Stock Performance

NASDAQ TROW traded down $0.63 during trading hours on Thursday, reaching $94.46. 1,540,975 shares of the company's stock were exchanged, compared to its average volume of 1,492,100. The company's 50-day moving average is $90.69 and its two-hundred day moving average is $105.50. T. Rowe Price Group, Inc. has a one year low of $77.85 and a one year high of $125.81. The company has a market capitalization of $20.81 billion, a price-to-earnings ratio of 10.31, a price-to-earnings-growth ratio of 2.86 and a beta of 1.50.

T. Rowe Price Group (NASDAQ:TROW - Get Free Report) last posted its earnings results on Friday, May 2nd. The asset manager reported $2.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.13 by $0.10. The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.80 billion. T. Rowe Price Group had a return on equity of 20.83% and a net margin of 29.61%. T. Rowe Price Group's revenue for the quarter was up .8% compared to the same quarter last year. During the same period in the prior year, the business earned $2.38 EPS. Research analysts predict that T. Rowe Price Group, Inc. will post 9.29 earnings per share for the current fiscal year.

T. Rowe Price Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 27th. Stockholders of record on Friday, June 13th will be paid a dividend of $1.27 per share. The ex-dividend date is Friday, June 13th. This represents a $5.08 annualized dividend and a dividend yield of 5.38%. T. Rowe Price Group's dividend payout ratio is currently 57.60%.

About T. Rowe Price Group

T. Rowe Price Group, Inc is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe.